{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:53:48Z","timestamp":1789080828715,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40273-026-01608-1","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:51:12Z","timestamp":1773215472000},"page":"775-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the Cost Effectiveness of Rapid Diagnostic Testing for the Identification of Pathogens and Resistance Genes in Bloodstream Infections"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-4659","authenticated-orcid":false,"given":"James K.","family":"Karichu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-8700","authenticated-orcid":false,"given":"Mark","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2426-4427","authenticated-orcid":false,"given":"Tiffeny T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8359-6336","authenticated-orcid":false,"given":"Adam","family":"Thornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"6","key":"1608_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12195.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1608_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmi.2019.11.017","volume":"26","author":"B Lamy","year":"2020","unstructured":"Lamy B, Sundqvist M, Idelevich EA, E. Escmid Study Group for Bloodstream Infections, and Sepsis. Bloodstream infections\u2014standard and progress in pathogen diagnostics. Clin Microbiol Infect. 2020;26(2):142\u201350. https:\/\/doi.org\/10.1016\/j.cmi.2019.11.017.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1608_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"JF Timsit","year":"2020","unstructured":"Timsit JF, Ruppe E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266\u201384. https:\/\/doi.org\/10.1007\/s00134-020-05950-6.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1608_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4265-z","volume":"19","author":"HF Leal","year":"2019","unstructured":"Leal HF, et al. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features. BMC Infect Dis. 2019;19(1):609. https:\/\/doi.org\/10.1186\/s12879-019-4265-z.","journal-title":"BMC Infect Dis"},{"key":"1608_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftac027","author":"SP Costa","year":"2022","unstructured":"Costa SP, Carvalho CM. Burden of bacterial bloodstream infections and recent advances for diagnosis. Pathog Dis. 2022. https:\/\/doi.org\/10.1093\/femspd\/ftac027.","journal-title":"Pathog Dis"},{"issue":"2","key":"1608_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7861\/clinmedicine.18-2-146","volume":"18","author":"T Evans","year":"2018","unstructured":"Evans T. Diagnosis and management of sepsis. Clin Med (Lond). 2018;18(2):146\u20139. https:\/\/doi.org\/10.7861\/clinmedicine.18-2-146.","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"1608_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.arcmed.2005.02.005","volume":"36","author":"GM Bearman","year":"2005","unstructured":"Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res. 2005;36(6):646\u201359. https:\/\/doi.org\/10.1016\/j.arcmed.2005.02.005.","journal-title":"Arch Med Res"},{"issue":"8","key":"1608_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/archinte.167.8.834","volume":"167","author":"DZ Uslan","year":"2007","unstructured":"Uslan DZ, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167(8):834\u20139. https:\/\/doi.org\/10.1001\/archinte.167.8.834.","journal-title":"Arch Intern Med"},{"key":"1608_CR9","unstructured":"Mada PK, Alam MU. Clostridioides difficile infection. StatPearls. 2024. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28613708. (in Eng)"},{"issue":"1","key":"1608_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1128\/AAC.00462-11","volume":"56","author":"P Retamar","year":"2012","unstructured":"Retamar P, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56(1):472\u20138. https:\/\/doi.org\/10.1128\/AAC.00462-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1608_CR11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","volume":"43","author":"SA Sterling","year":"2015","unstructured":"Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med. 2015;43(9):1907.","journal-title":"Crit Care Med"},{"issue":"1","key":"1608_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1128\/CMR.00053-14","volume":"29","author":"SS Buehler","year":"2016","unstructured":"Buehler SS, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev. 2016;29(1):59\u2013103. https:\/\/doi.org\/10.1128\/CMR.00053-14.","journal-title":"Clin Microbiol Rev"},{"key":"1608_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11040427","author":"I Gajic","year":"2022","unstructured":"Gajic I, et al. Antimicrobial susceptibility testing: a comprehensive review of currently used methods. Antibiotics (Basel). 2022. https:\/\/doi.org\/10.3390\/antibiotics11040427.","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"1608_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cmi.2018.05.007","volume":"24","author":"N Peker","year":"2018","unstructured":"Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin Microbiol Infect. 2018;24(9):944\u201355. https:\/\/doi.org\/10.1016\/j.cmi.2018.05.007.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1608_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12866-021-02403-y","volume":"21","author":"DTT Sze","year":"2021","unstructured":"Sze DTT, Lau CCY, Chan TM, Ma ESK, Tang BSF. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels. BMC Microbiol. 2021;21(1):350. https:\/\/doi.org\/10.1186\/s12866-021-02403-y.","journal-title":"BMC Microbiol"},{"issue":"7","key":"1608_CR16","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1128\/JCM.00376-16","volume":"54","author":"T Walker","year":"2016","unstructured":"Walker T, et al. Clinical Impact of laboratory implementation of verigene BC-GN microarray-based assay for detection of gram-negative bacteria in positive blood cultures. J Clin Microbiol. 2016;54(7):1789\u201396. https:\/\/doi.org\/10.1128\/JCM.00376-16.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1608_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.diagmicrobio.2019.02.018","volume":"94","author":"F Shehadeh","year":"2019","unstructured":"Shehadeh F, Zacharioudakis IM, Zervou FN, Mylonakis E. Cost-effectiveness of rapid diagnostic assays that perform directly on blood samples for the diagnosis of septic shock. Diagn Microbiol Infect Dis. 2019;94(4):378\u201384. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.02.018.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1608_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2022.101056","volume":"32","author":"M Vankelegom","year":"2022","unstructured":"Vankelegom M, et al. Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland. Informatics Med Unlocked. 2022;32:101056.","journal-title":"Informatics Med Unlocked"},{"issue":"2","key":"1608_CR19","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.1093\/ofid\/ofz360.726","volume":"6","author":"I Zacharioudakis","year":"2019","unstructured":"Zacharioudakis I, Zervou F, Shehaded F, Eng M, Mylonakis E, Mylonakis E. Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department. Open Forum Infect Dis. 2019;6(2):S302.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1608_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jac\/dkab398","volume":"77","author":"K Mponponsuo","year":"2022","unstructured":"Mponponsuo K, Leal J, Spackman E, Somayaji R, Gregson D, Rennert-May E. Mathematical model of the cost-effectiveness of the BioFire FilmArray Blood Culture Identification (BCID) Panel molecular rapid diagnostic test compared with conventional methods for identification of Escherichia coli bloodstream infections. J Antimicrob Chemother. 2022;77(2):507\u201316. https:\/\/doi.org\/10.1093\/jac\/dkab398.","journal-title":"J Antimicrob Chemother"},{"key":"1608_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00095-17","author":"EE Pliakos","year":"2018","unstructured":"Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E. The cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clin Microbiol Rev. 2018. https:\/\/doi.org\/10.1128\/CMR.00095-17.","journal-title":"Clin Microbiol Rev"},{"key":"1608_CR22","unstructured":"Institute for Clinical and Economic Review (ICER), \"ICER\u2019s Reference Case for Economic Evaluations: Elements and Rationale. Available at: https:\/\/icer.org\/wp-content\/uploads\/2023\/10\/ICER_Reference-Case_For-Publication_Sept2023.pdf. 2023. Accessed Feb 2025."},{"issue":"11","key":"1608_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"1608_CR24","unstructured":"National Institute of Health and Care Excellence. Sepsis: recognition, diagnosis and early management. NICE guideline [NG51]. https:\/\/www.nice.org.uk\/guidance\/ng51. Accessed 9 Jan 2023."},{"key":"1608_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01730-19","author":"KC Carroll","year":"2020","unstructured":"Carroll KC, et al. Clinical performance of the novel GenMark Dx ePlex blood culture ID Gram-Positive panel. J Clin Microbiol. 2020. https:\/\/doi.org\/10.1128\/JCM.01730-19.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1608_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1128\/JCM.02264-16","volume":"55","author":"K Messacar","year":"2017","unstructured":"Messacar K, Parker SK, Todd JK, Dominguez SR. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol. 2017;55(3):715\u201323. https:\/\/doi.org\/10.1128\/JCM.02264-16.","journal-title":"J Clin Microbiol"},{"key":"1608_CR27","unstructured":"Eigner U, Holfelder M, Oberdorfer K, Betz-Wild U, Bertsch D, Fahr AM. Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab. 2009; 55(7-8):289\u201396. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19894408."},{"issue":"12","key":"1608_CR28","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1128\/JCM.00868-17","volume":"55","author":"ML Faron","year":"2017","unstructured":"Faron ML, Buchan BW, Ledeboer NA. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for use with positive blood cultures: methodology, performance, and optimization. J Clin Microbiol. 2017;55(12):3328\u201338. https:\/\/doi.org\/10.1128\/JCM.00868-17.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1608_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00137-24","volume":"38","author":"DM Wolk","year":"2025","unstructured":"Wolk DM, et al. The American Society for Microbiology\u2019s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: A systematic review and meta-analysis. Clin Microbiol Rev. 2025;38(3):e0013724. https:\/\/doi.org\/10.1128\/cmr.00137-24.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1608_CR30","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","volume":"57","author":"KA Brown","year":"2013","unstructured":"Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326\u201332. https:\/\/doi.org\/10.1128\/AAC.02176-12.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1608_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02512-3","volume":"21","author":"T Chinzowu","year":"2021","unstructured":"Chinzowu T, Roy S, Nishtala PS. Risk of antimicrobial-associated organ injury among the older adults: A systematic review and meta-analysis. BMC Geriatr. 2021;21(1):617. https:\/\/doi.org\/10.1186\/s12877-021-02512-3.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1608_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma T, et al. Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw Open. 2023;6(1):e2249353. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49353.","journal-title":"JAMA Netw Open"},{"key":"1608_CR33","unstructured":"\"BioFire FilmArray Blood Culture Identification Panel. Product data. Available at: https:\/\/www.biofiredx.com\/wp-content\/uploads\/2016\/03\/IS-FLM1-PRT-0069-04-FilmArray-Blood-Culture-Identification-Panel-Information-Sheet.pdf. Accessed 3 Feb 25."},{"key":"1608_CR34","unstructured":"\"BIOFIRE\u00ae Blood Culture Identification 2 (BCID2) Panel. Product information. Available at: https:\/\/www.biomerieux.com\/corp\/en\/our-offer\/clinical-products\/biofire-blood-culture-identification-2-panel.html? Accessed 3 Feb 25."},{"key":"1608_CR35","unstructured":"\"Verigene\u00ae Gram-Negative Blood Culture Nucleic Acid Test (BC-GN). Product information. Available at: http:\/\/www.nanosphere.us\/sites\/default\/files\/support-docs\/nanosphere_bcgn_insert_final.pdf. Accessed 3 Feb 25."},{"key":"1608_CR36","unstructured":"\"VERIGENE Gram-Positive Blood Culture Test. Product information. Available at: https:\/\/int.diasorin.com\/en\/molecular-diagnostics\/kits-reagents\/verigene-gram-positive-blood-culture-test-bc-gp. Accessed 3 Feb 25."},{"key":"1608_CR37","unstructured":"\"Accelerate PhenoTest BC Kit. Product information. Available at: https:\/\/acceleratediagnostics.com\/products\/accelerate-phenotest-bc\/#features. Accessed 3 Feb 25."},{"key":"1608_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01597-18","author":"TD Huang","year":"2019","unstructured":"Huang TD, Melnik E, Bogaerts P, Evrard S, Glupczynski Y. Evaluation of the ePlex blood culture identification panels for detection of pathogens in bloodstream infections. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01597-18.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1608_CR39","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1128\/JCM.00529-14","volume":"52","author":"RM Martinez","year":"2014","unstructured":"Martinez RM, Bauerle ER, Fang FC, Butler-Wu SM. Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures. J Clin Microbiol. 2014;52(7):2521\u20139. https:\/\/doi.org\/10.1128\/JCM.00529-14.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1608_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cmi.2024.12.007","volume":"31","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Performance of molecular tests for diagnosis of bloodstream infections in the clinical setting: a systematic literature review and meta-analysis. Clin Microbiol Infect. 2025;31(3):360\u201372. https:\/\/doi.org\/10.1016\/j.cmi.2024.12.007.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1608_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19(4):788\u2013802. https:\/\/doi.org\/10.1128\/CMR.00062-05.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1608_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2080-3","volume":"16","author":"P Liu","year":"2016","unstructured":"Liu P, Ohl C, Johnson J, Williamson J, Beardsley J, Luther V. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program. BMC Infect Dis. 2016;16(1):751. https:\/\/doi.org\/10.1186\/s12879-016-2080-3.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1608_CR43","doi-asserted-by":"publisher","first-page":"e0242921","DOI":"10.1128\/jcm.02429-21","volume":"60","author":"M Verway","year":"2022","unstructured":"Verway M, et al. Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study. J Clin Microbiol. 2022;60(4):e0242921. https:\/\/doi.org\/10.1128\/jcm.02429-21.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1608_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/icvts\/ivx320","volume":"26","author":"T Tauriainen","year":"2018","unstructured":"Tauriainen T, et al. Transfusion and blood stream infections after coronary surgery. Interact Cardiovasc Thorac Surg. 2018;26(2):325\u20137. https:\/\/doi.org\/10.1093\/icvts\/ivx320.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"1608_CR45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cid\/ciac727","volume":"76","author":"J Van Heuverswyn","year":"2023","unstructured":"Van Heuverswyn J, Valik JK, van der Werff SD, Hedberg P, Giske C, Naucler P. Association between time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: a retrospective cohort study. Clin Infect Dis. 2023;76(3):469\u201378. https:\/\/doi.org\/10.1093\/cid\/ciac727.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1608_CR46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkw402","volume":"72","author":"SE Battle","year":"2017","unstructured":"Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017;72(1):299\u2013304. https:\/\/doi.org\/10.1093\/jac\/dkw402.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1608_CR47","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1128\/JCM.41.7.3119-3125.2003","volume":"41","author":"SE Beekmann","year":"2003","unstructured":"Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 2003;41(7):3119\u201325. https:\/\/doi.org\/10.1128\/JCM.41.7.3119-3125.2003.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1608_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/cid\/cir301","volume":"53","author":"V Stevens","year":"2011","unstructured":"Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42\u20138. https:\/\/doi.org\/10.1093\/cid\/cir301.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1608_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jhm.2199","volume":"9","author":"T Lagu","year":"2014","unstructured":"Lagu T, et al. The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis. J Hosp Med. 2014;9(7):411\u20137. https:\/\/doi.org\/10.1002\/jhm.2199.","journal-title":"J Hosp Med"},{"issue":"2","key":"1608_CR50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jhin.2018.06.003","volume":"100","author":"S Manoukian","year":"2018","unstructured":"Manoukian S, et al. Estimating excess length of stay due to healthcare-associated infections: a systematic review and meta-analysis of statistical methodology. J Hosp Infect. 2018;100(2):222\u201335. https:\/\/doi.org\/10.1016\/j.jhin.2018.06.003.","journal-title":"J Hosp Infect"},{"issue":"4","key":"1608_CR51","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/AAC.01602-07","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52(4):1330\u20136. https:\/\/doi.org\/10.1128\/AAC.01602-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1608_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/jac\/dkad351","volume":"79","author":"TP Lodise","year":"2024","unstructured":"Lodise TP, Yucel E, Obi EN, Watanabe AH, Nathanson BH. Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant gram-negative infections who received targeted treatment with a newer \u03b2-lactam or \u03b2-lactam\/\u03b2-lactamase inhibitor-, polymyxin-or aminoglycoside-containing regimen. J Antimicrob Chemother. 2024;79(1):82\u201395.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1608_CR53","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/AAC.00173-11","volume":"55","author":"E Minejima","year":"2011","unstructured":"Minejima E, Choi J, Beringer P, Lou M, Tse E, Wong-Beringer A. Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients. Antimicrob Agents Chemother. 2011;55(7):3278\u201383. https:\/\/doi.org\/10.1128\/AAC.00173-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1608_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"1608_CR55","unstructured":"British National Formulary (BNF). Available at: https:\/\/bnf.nice.org.uk\/. Accessed Oct 2024."},{"key":"1608_CR56","unstructured":"US Department of Veteran Affairs, \"VA Drug Pricing database. Available at: https:\/\/www.data.va.gov\/dataset\/VA-Drug-Pricing-Database\/pu94-4asd\/about_data. 2020. Accessed Aug 2024."},{"issue":"8","key":"1608_CR57","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1128\/JCM.00833-15","volume":"53","author":"A Tran","year":"2015","unstructured":"Tran A, Alby K, Kerr A, Jones M, Gilligan PH. Cost savings realized by implementation of routine microbiological identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol. 2015;53(8):2473\u20139. https:\/\/doi.org\/10.1128\/JCM.00833-15.","journal-title":"J Clin Microbiol"},{"key":"1608_CR58","unstructured":"Kaiser Family Foundation, \"Hospital adjusted expenses per inpatient day. Data source: 1999-2018 AHA annual survey. Available at: https:\/\/www.kff.org\/state-category\/health-costs-budgets\/hospital-inpatient-day-expenses\/. Accessed Aug 2024."},{"key":"1608_CR59","unstructured":"E. Aria and J. Xu, \"United States life tables, 2020. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/118055. 2022. Accessed Aug 2024."},{"issue":"2","key":"1608_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10198-018-0955-5","volume":"20","author":"MF Janssen","year":"2019","unstructured":"Janssen MF, Szende A, Cabses J, Ramos-Goni JM, Vilagut G, Konig HH. Population norms for the EQ-5D-3L: A cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205\u201316. https:\/\/doi.org\/10.1007\/s10198-018-0955-5.","journal-title":"Eur J Health Econ"},{"key":"1608_CR61","unstructured":"GOV.UK, \"UK Integrated Online Tariff. December 2024 average exchange rates. Available at: https:\/\/www.trade-tariff.service.gov.uk\/exchange_rates\/view\/2024-12?type=average. 2024. Accessed Feb 2026."},{"key":"1608_CR62","unstructured":"Organisation for Economic Co-operation and Development (OECD), \"Purchasing power parities (PPP). Available at: https:\/\/www.oecd.org\/en\/data\/indicators\/purchasing-power-parities-ppp.html. 2024. Accessed Feb 2026."},{"key":"1608_CR63","unstructured":"Hern\u00e1ndez Alava M, Pudney SAW. Estimating EQ-5D by age and sex for the uK. NICE DSU Report. 2022."},{"key":"1608_CR64","unstructured":"National Institute of Health and Care Excellence (NICE), \"Changes to NICE\u2019s cost-effectiveness thresholds confirmed. Available at: https:\/\/www.nice.org.uk\/news\/articles\/changes-to-nice-s-cost-effectiveness-thresholds-confirmed. 2025. Accessed Feb 2026."},{"issue":"4","key":"1608_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0272989X20916450","volume":"40","author":"MO Soares","year":"2020","unstructured":"Soares MO, Sculpher MJ, Claxton K. Health opportunity costs: Assessing the implications of uncertainty using elicitation methods with experts. Med Decis Making. 2020;40(4):448\u201359. https:\/\/doi.org\/10.1177\/0272989X20916450.","journal-title":"Med Decis Making"},{"issue":"1","key":"1608_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11010027","volume":"11","author":"P Rojas-Garcia","year":"2021","unstructured":"Rojas-Garcia P, et al. Diagnostic testing for sepsis: a systematic review of economic evaluations. Antibiotics (Basel). 2021;11(1):27. https:\/\/doi.org\/10.3390\/antibiotics11010027.","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"1608_CR67","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cmi.2020.01.030","volume":"26","author":"A MacGowan","year":"2020","unstructured":"MacGowan A, et al. Impact of rapid microbial identification on clinical outcomes in bloodstream infection: The RAPIDO randomized trial. Clin Microbiol Infect. 2020;26(10):1347\u201354. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.030.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1608_CR68","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10096-024-04820-z","volume":"43","author":"Y Caspar","year":"2024","unstructured":"Caspar Y, et al. Clinical impact and cost-consequence analysis of ePlex(R) blood culture identification panels for the rapid diagnosis of bloodstream infections: A single-center randomized controlled trial. Eur J Clin Microbiol Infect Dis. 2024;43(6):1193\u2013203. https:\/\/doi.org\/10.1007\/s10096-024-04820-z.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01608-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:41:18Z","timestamp":1779201678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01608-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01608-1","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JKK and AT are employees of Roche Molecular Systems (RMS). JKK and AT hold Roche stock options. TS is an employee of Roche Diagnostics Corporation (RDC)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The analysis used secondary data sources which are publicly available. No primary individual patient data was collected or used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The analysis used secondary data sources. No individual patient data was collected or used. Consequently, ethical approval for the study was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"No individual patient data was collected or used, and hence consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The economic model is considered commercially sensitive, and we are unable to provide access to it.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"JKK and AT conceived the study. MP, JKK, AT and KL designed the study. MP, JKK, AT, TS and XB compiled the data. MP, JKK, AT, TS, KL and XB reviewed the results. MP drafted the manuscript. MP, JKK, AT, TS, KL and XB reviewed the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}